Published in Curr Chem Genomics on January 01, 2008
Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment. Pharmacol Ther (2011) 1.71
The role of glutamate signaling in the pathogenesis and treatment of obsessive-compulsive disorder. Pharmacol Biochem Behav (2011) 1.29
A critical review of magnetic resonance spectroscopy studies of obsessive-compulsive disorder. Biol Psychiatry (2012) 1.07
Slitrks as emerging candidate genes involved in neuropsychiatric disorders. Trends Neurosci (2011) 1.04
Candidate genes and functional noncoding variants identified in a canine model of obsessive-compulsive disorder. Genome Biol (2014) 1.04
Association between the NMDA glutamate receptor GRIN2B gene and obsessive-compulsive disorder. J Psychiatry Neurosci (2012) 0.85
Annual Research Review: Transgenic mouse models of childhood-onset psychiatric disorders. J Child Psychol Psychiatry (2011) 0.84
Glutamate-system defects behind psychiatric manifestations in a familial hemiplegic migraine type 2 disease-mutation mouse model. Sci Rep (2016) 0.82
An inherited small microdeletion at 15q13.3 in a patient with early-onset obsessive-compulsive disorder. PLoS One (2014) 0.79
Role of lamotrigine augmentation in treatment-resistant obsessive compulsive disorder: a retrospective case review from South Asia. Indian J Psychol Med (2015) 0.75
Glutamate modulators in the treatment of obsessive-compulsive disorder. Psychiatr Ann (2015) 0.75
Deep brain light stimulation effects on glutamate and dopamine concentration. Biomed Opt Express (2014) 0.75
Glutamatergic agents for OCD and related disorders. Curr Treat Options Psychiatry (2015) 0.75
From Thought to Action: How the Interplay Between Neuroscience and Phenomenology Changed Our Understanding of Obsessive-Compulsive Disorder. Front Psychol (2015) 0.75
Disruption of Ninjurin1 Leads to Repetitive and Anxiety-Like Behaviors in Mice. Mol Neurobiol (2016) 0.75
Global and local excitation and inhibition shape the dynamics of the cortico-striatal-thalamo-cortical pathway. Sci Rep (2017) 0.75
Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci (1986) 18.17
PDZ domain proteins of synapses. Nat Rev Neurosci (2004) 8.14
NMDA receptor subunits: diversity, development and disease. Curr Opin Neurobiol (2001) 6.96
NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders. Nat Rev Neurosci (2007) 6.26
Localization of neuronal and glial glutamate transporters. Neuron (1994) 5.14
Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice. Nature (2007) 4.59
Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of D-cycloserine as assessed with fear-potentiated startle in rats. J Neurosci (2002) 4.52
Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors. Nature (1995) 4.36
Frontal-subcortical neuronal circuits and clinical neuropsychiatry: an update. J Psychosom Res (2002) 4.17
Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry (1998) 3.80
Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. Science (1998) 3.70
Augmentation of behavior therapy with D-cycloserine for obsessive-compulsive disorder. Am J Psychiatry (2008) 3.63
The basal ganglia and chunking of action repertoires. Neurobiol Learn Mem (1998) 3.55
Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: the orbitofronto-striatal model revisited. Neurosci Biobehav Rev (2007) 3.51
Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. Am J Psychiatry (2005) 3.38
Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry. Brain Res Brain Res Rev (1995) 3.32
The epidemiology of obsessive-compulsive disorder in five US communities. Arch Gen Psychiatry (1988) 3.15
Metabotropic glutamate receptors as novel targets for anxiety and stress disorders. Nat Rev Drug Discov (2005) 3.15
Cystine/glutamate exchange regulates metabotropic glutamate receptor presynaptic inhibition of excitatory transmission and vulnerability to cocaine seeking. J Neurosci (2005) 3.08
D-cycloserine augmented exposure therapy for obsessive-compulsive disorder. Biol Psychiatry (2007) 3.03
GKAP, a novel synaptic protein that interacts with the guanylate kinase-like domain of the PSD-95/SAP90 family of channel clustering molecules. J Cell Biol (1997) 2.92
Fear and the brain: where have we been, and where are we going? Biol Psychiatry (1998) 2.89
The cross national epidemiology of obsessive compulsive disorder. The Cross National Collaborative Group. J Clin Psychiatry (1994) 2.73
Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography. Arch Gen Psychiatry (1994) 2.70
Hoxb8 is required for normal grooming behavior in mice. Neuron (2002) 2.67
The basal ganglia. Curr Biol (2000) 2.64
Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system. J Pharmacol Exp Ther (2001) 2.55
Practice guideline for the treatment of patients with obsessive-compulsive disorder. Am J Psychiatry (2007) 2.53
Linkage and association of the glutamate receptor 6 gene with autism. Mol Psychiatry (2002) 2.51
Hyperactivity and impaired response habituation in hyperdopaminergic mice. Proc Natl Acad Sci U S A (2001) 2.46
The psychological treatment of obsessive-compulsive disorder. Can J Psychiatry (2006) 2.40
Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Arch Gen Psychiatry (1992) 2.31
Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder. Psychiatr Clin North Am (2000) 2.24
SAPAPs. A family of PSD-95/SAP90-associated proteins localized at postsynaptic density. J Biol Chem (1997) 2.23
Glutamate transporter gene SLC1A1 associated with obsessive-compulsive disorder. Arch Gen Psychiatry (2006) 2.23
Neurotransmission in the rat amygdala related to fear and anxiety. Trends Neurosci (1994) 2.09
The nucleus accumbens: a target for deep brain stimulation in obsessive-compulsive- and anxiety-disorders. J Chem Neuroanat (2003) 2.08
Association testing of the positional and functional candidate gene SLC1A1/EAAC1 in early-onset obsessive-compulsive disorder. Arch Gen Psychiatry (2006) 2.02
Hyperdopaminergic mutant mice have higher "wanting" but not "liking" for sweet rewards. J Neurosci (2003) 2.00
Local cerebral glucose metabolic rates in obsessive-compulsive disorder. A comparison with rates in unipolar depression and in normal controls. Arch Gen Psychiatry (1987) 1.98
Neurophysiologic dysfunction in basal ganglia/limbic striatal and thalamocortical circuits as a pathogenetic mechanism of obsessive-compulsive disorder. J Neuropsychiatry Clin Neurosci (1989) 1.98
Riluzole inhibits the persistent sodium current in mammalian CNS neurons. Eur J Neurosci (2000) 1.95
Compulsive hoarding: current status of the research. Clin Psychol Rev (2003) 1.93
A.E. Bennett Research Award. Toward a neurodevelopmental model of of obsessive--compulsive disorder. Biol Psychiatry (1998) 1.88
The glutamate/neutral amino acid transporter family SLC1: molecular, physiological and pharmacological aspects. Pflugers Arch (2003) 1.75
Clinical practice. Obsessive-compulsive disorder. N Engl J Med (2004) 1.70
Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Revisualization during pharmacotherapy. Arch Gen Psychiatry (1992) 1.69
Cerebral glucose metabolic rates in nondepressed patients with obsessive-compulsive disorder. Am J Psychiatry (1988) 1.68
Orbital frontal and amygdala volume reductions in obsessive-compulsive disorder. Arch Gen Psychiatry (1999) 1.61
Deep brain stimulation for refractory obsessive-compulsive disorder. Biol Psychiatry (2005) 1.59
Functional anatomy of obsessive-compulsive phenomena. Br J Psychiatry (1994) 1.57
Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Arch Gen Psychiatry (1989) 1.56
Patterns of brain activity associated with variation in voluntary wheel-running behavior. Behav Neurosci (2003) 1.54
Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial. Biol Psychiatry (2005) 1.52
PANDAS: current status and directions for research. Mol Psychiatry (2004) 1.50
Long-term electrical capsular stimulation in patients with obsessive-compulsive disorder. Neurosurgery (2003) 1.49
Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder. Arch Gen Psychiatry (1996) 1.47
Trapping channel block of NMDA-activated responses by amantadine and memantine. J Neurophysiol (1997) 1.46
D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder. Int Clin Psychopharmacol (2007) 1.46
Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder. NeuroRx (2006) 1.43
Riluzole enhances glutamate uptake in rat astrocyte cultures. Cell Mol Neurobiol (2004) 1.43
Twin studies on obsessive-compulsive disorder: a review. Twin Res Hum Genet (2005) 1.41
Pathophysiology of obsessive-compulsive disorder: a necessary link between phenomenology, neuropsychology, imagery and physiology. Prog Neurobiol (2004) 1.40
High-frequency deep brain stimulation of the nucleus accumbens region suppresses neuronal activity and selectively modulates afferent drive in rat orbitofrontal cortex in vivo. J Neurosci (2007) 1.39
Association of a glutamate (NMDA) subunit receptor gene (GRIN2B) with obsessive-compulsive disorder: a preliminary study. Psychopharmacology (Berl) (2004) 1.39
Multiple rare SAPAP3 missense variants in trichotillomania and OCD. Mol Psychiatry (2009) 1.37
Glutamatergic dysfunction in OCD. Neuropsychopharmacology (2005) 1.36
Genome-wide linkage analysis of families with obsessive-compulsive disorder ascertained through pediatric probands. Am J Med Genet (2002) 1.35
N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorder. Psychopharmacology (Berl) (2005) 1.31
Sequential super-stereotypy of an instinctive fixed action pattern in hyper-dopaminergic mutant mice: a model of obsessive compulsive disorder and Tourette's. BMC Biol (2005) 1.30
Family-based association studies support a sexually dimorphic effect of COMT and MAOA on genetic susceptibility to obsessive-compulsive disorder. Biol Psychiatry (1999) 1.29
D-cycloserine, a positive modulator of the N-methyl-D-aspartate receptor, enhances performance of learning tasks in rats. Pharmacol Biochem Behav (1989) 1.29
The met(158) allele of catechol-O-methyltransferase (COMT) is associated with obsessive-compulsive disorder in men: case-control study and meta-analysis. Mol Psychiatry (2007) 1.28
Valproate attenuates hyperactive and perseverative behaviors in mutant mice with a dysregulated dopamine system. Biol Psychiatry (2003) 1.28
Association of the SLC1A1 glutamate transporter gene and obsessive-compulsive disorder. Am J Med Genet B Neuropsychiatr Genet (2007) 1.27
Effectiveness of exposure and ritual prevention for obsessive-compulsive disorder: randomized compared with nonrandomized samples. J Consult Clin Psychol (2000) 1.27
Localized orbitofrontal and subcortical metabolic changes and predictors of response to paroxetine treatment in obsessive-compulsive disorder. Neuropsychopharmacology (1999) 1.26
Differential mRNA expression and protein localization of the SAP90/PSD-95-associated proteins (SAPAPs) in the nervous system of the mouse. J Comp Neurol (2004) 1.25
Riluzole in the treatment of mood and anxiety disorders. CNS Drugs (2008) 1.24
Mechanisms underlying the riluzole inhibition of glutamate release from rat cerebral cortex nerve terminals (synaptosomes). Neuroscience (2004) 1.24
Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive-compulsive disorder. Proc Natl Acad Sci U S A (1997) 1.24
[18F]FDG PET study in obsessive-compulsive disorder. A clinical/metabolic correlation study after treatment. Br J Psychiatry (1995) 1.23
High prevalence of obsessive-compulsive symptoms in patients with Sydenham's chorea. Am J Psychiatry (1989) 1.21
Modulation of extracellular glutamate concentration in rat brain slices by cystine-glutamate exchange. J Physiol (1999) 1.18
Modification of expectations in cases with obsessional rituals. Behav Res Ther (1966) 1.18
Speculations on the functional anatomy of basal ganglia disorders. Annu Rev Neurosci (1983) 1.18
D-cycloserine acts as a partial agonist at the glycine modulatory site of the NMDA receptor expressed in Xenopus oocytes. Brain Res (1990) 1.15
Current animal models of obsessive compulsive disorder: a critical review. Prog Neuropsychopharmacol Biol Psychiatry (2006) 1.15
Hox genes and mammalian development. Cold Spring Harb Symp Quant Biol (1997) 1.15
DAP-1, a novel protein that interacts with the guanylate kinase-like domains of hDLG and PSD-95. Genes Cells (1997) 1.15
Replication study supports evidence for linkage to 9p24 in obsessive-compulsive disorder. Am J Hum Genet (2004) 1.13
Post-treatment effects of exposure therapy and clomipramine in obsessive-compulsive disorder. Depress Anxiety (2004) 1.13
Probing striatal function in obsessive-compulsive disorder: a PET study of implicit sequence learning. J Neuropsychiatry Clin Neurosci (1997) 1.12
A transgenic model of comorbid Tourette's syndrome and obsessive-compulsive disorder circuitry. Mol Psychiatry (2002) 1.10
An open-label trial of riluzole, a glutamate antagonist, in children with treatment-resistant obsessive-compulsive disorder. J Child Adolesc Psychopharmacol (2007) 1.10
Compulsive behavior in the 5-HT2C receptor knockout mouse. Physiol Behav (2003) 1.08
Local cerebral glucose metabolic rates in obsessive-compulsive disorder. Patients treated with clomipramine. Arch Gen Psychiatry (1990) 1.07
Topiramate reduces AMPA-induced Ca(2+) transients and inhibits GluR1 subunit phosphorylation in astrocytes from primary cultures. J Neurochem (2005) 1.06
Long-term in vivo imaging of experience-dependent synaptic plasticity in adult cortex. Nature (2002) 11.85
In vivo light-induced activation of neural circuitry in transgenic mice expressing channelrhodopsin-2. Neuron (2007) 7.59
A transcription activator-like effector toolbox for genome engineering. Nat Protoc (2012) 6.81
Shank3 mutant mice display autistic-like behaviours and striatal dysfunction. Nature (2011) 5.62
Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice. Nature (2007) 4.59
Cell type–specific channelrhodopsin-2 transgenic mice for optogenetic dissection of neural circuitry function. Nat Methods (2011) 4.02
Next-generation optical technologies for illuminating genetically targeted brain circuits. J Neurosci (2006) 3.95
Sustained axon regeneration induced by co-deletion of PTEN and SOCS3. Nature (2011) 3.18
Dynamic remodeling of dendritic arbors in GABAergic interneurons of adult visual cortex. PLoS Biol (2005) 2.61
Genetic evidence that relative synaptic efficacy biases the outcome of synaptic competition. Nature (2003) 2.51
Optogenetic stimulation of lateral orbitofronto-striatal pathway suppresses compulsive behaviors. Science (2013) 2.21
Habenula "cholinergic" neurons co-release glutamate and acetylcholine and activate postsynaptic neurons via distinct transmission modes. Neuron (2011) 2.14
Improved expression of halorhodopsin for light-induced silencing of neuronal activity. Brain Cell Biol (2008) 2.12
Postsynaptic requirement for Abl kinases in assembly of the neuromuscular junction. Nat Neurosci (2003) 2.03
The primordial, blue-cone color system of the mouse retina. J Neurosci (2005) 1.94
Visual function in mice with photoreceptor degeneration and transgenic expression of channelrhodopsin 2 in ganglion cells. J Neurosci (2010) 1.87
Synaptic dynamism measured over minutes to months: age-dependent decline in an autonomic ganglion. Nat Neurosci (2003) 1.77
Selective optical drive of thalamic reticular nucleus generates thalamic bursts and cortical spindles. Nat Neurosci (2011) 1.74
The histone deacetylase HDAC4 connects neural activity to muscle transcriptional reprogramming. J Biol Chem (2007) 1.70
Two-photon imaging reveals somatodendritic chloride gradient in retinal ON-type bipolar cells expressing the biosensor Clomeleon. Neuron (2006) 1.63
Calcium channel alpha2delta1 subunit mediates spinal hyperexcitability in pain modulation. Pain (2006) 1.61
Progressive NKCC1-dependent neuronal chloride accumulation during neonatal seizures. J Neurosci (2010) 1.50
Single-neuron labeling with inducible Cre-mediated knockout in transgenic mice. Nat Neurosci (2008) 1.43
The chloride transporter Na(+)-K(+)-Cl- cotransporter isoform-1 contributes to intracellular chloride increases after in vitro ischemia. J Neurosci (2006) 1.42
Differences in cortical versus subcortical GABAergic signaling: a candidate mechanism of electroclinical uncoupling of neonatal seizures. Neuron (2009) 1.42
Imaging neural activity using Thy1-GCaMP transgenic mice. Neuron (2012) 1.40
Downregulation of NR3A-containing NMDARs is required for synapse maturation and memory consolidation. Neuron (2009) 1.31
Close homolog of L1 modulates area-specific neuronal positioning and dendrite orientation in the cerebral cortex. Neuron (2004) 1.28
PSD93 regulates synaptic stability at neuronal cholinergic synapses. J Neurosci (2004) 1.26
Monoacylglycerol lipase is a therapeutic target for Alzheimer's disease. Cell Rep (2012) 1.25
Differential mRNA expression and protein localization of the SAP90/PSD-95-associated proteins (SAPAPs) in the nervous system of the mouse. J Comp Neurol (2004) 1.25
Imaging synaptic inhibition in transgenic mice expressing the chloride indicator, Clomeleon. Brain Cell Biol (2008) 1.21
ChAT-ChR2-EYFP mice have enhanced motor endurance but show deficits in attention and several additional cognitive domains. J Neurosci (2013) 1.20
Acute brain slice methods for adult and aging animals: application of targeted patch clamp analysis and optogenetics. Methods Mol Biol (2014) 1.14
Functional consequences of mutations in postsynaptic scaffolding proteins and relevance to psychiatric disorders. Annu Rev Neurosci (2012) 1.13
Reduced glutathione depletion causes necrosis and sensitization to tumor necrosis factor-alpha-induced apoptosis in cultured mouse hepatocytes. Hepatology (2002) 1.13
Neurobiology of obsessive-compulsive disorder: insights into neural circuitry dysfunction through mouse genetics. Curr Opin Neurobiol (2011) 1.07
3D-reconstruction and functional properties of GFP-positive and GFP-negative granule cells in the fascia dentata of the Thy1-GFP mouse. Hippocampus (2008) 1.06
Ubiquilin-1 regulates nicotine-induced up-regulation of neuronal nicotinic acetylcholine receptors. J Biol Chem (2005) 1.05
Candidate genes and functional noncoding variants identified in a canine model of obsessive-compulsive disorder. Genome Biol (2014) 1.04
Regulation of synaptic growth and maturation by a synapse-associated E3 ubiquitin ligase at the neuromuscular junction. J Cell Biol (2007) 1.04
Cellular and synaptic network defects in autism. Curr Opin Neurobiol (2012) 1.02
Sapap3 deletion causes mGluR5-dependent silencing of AMPAR synapses. J Neurosci (2011) 1.02
Normal midbrain dopaminergic neuron development and function in miR-133b mutant mice. J Neurosci (2012) 1.02
Sapap3 deletion anomalously activates short-term endocannabinoid-mediated synaptic plasticity. J Neurosci (2011) 1.02
Labeling neurons in vivo for morphological and functional studies. Curr Opin Neurobiol (2004) 1.02
Next-generation transgenic mice for optogenetic analysis of neural circuits. Front Neural Circuits (2013) 1.01
Development of transgenic animals for optogenetic manipulation of mammalian nervous system function: progress and prospects for behavioral neuroscience. Behav Brain Res (2013) 1.00
Imaging synaptic inhibition throughout the brain via genetically targeted Clomeleon. Brain Cell Biol (2008) 0.99
Cortical control of affective networks. J Neurosci (2013) 0.97
Genetic perturbation of postsynaptic activity regulates synapse elimination in developing cerebellum. Proc Natl Acad Sci U S A (2009) 0.96
Fluorescent labeling of newborn dentate granule cells in GAD67-GFP transgenic mice: a genetic tool for the study of adult neurogenesis. PLoS One (2010) 0.95
Optical inhibition of motor nerve and muscle activity in vivo. Muscle Nerve (2013) 0.94
Lamina-specific distribution of Synaptopodin, an actin-associated molecule essential for the spine apparatus, in identified principal cell dendrites of the mouse hippocampus. J Comp Neurol (2005) 0.93
Enhanced pre-synaptic glutamate release in deep-dorsal horn contributes to calcium channel alpha-2-delta-1 protein-mediated spinal sensitization and behavioral hypersensitivity. Mol Pain (2009) 0.91
Intersectional Cre driver lines generated using split-intein mediated split-Cre reconstitution. Sci Rep (2012) 0.88
LNX1 is a perisynaptic Schwann cell specific E3 ubiquitin ligase that interacts with ErbB2. Mol Cell Neurosci (2005) 0.87
In vivo imaging of juxtaglomerular neuron turnover in the mouse olfactory bulb. Proc Natl Acad Sci U S A (2006) 0.87
Pulse labeling and long-term tracing of newborn neurons in the adult subgranular zone. Cell Res (2010) 0.87
Imaging synaptic inhibition with the genetically encoded chloride indicator Clomeleon. Cold Spring Harb Protoc (2011) 0.86
Annual Research Review: Transgenic mouse models of childhood-onset psychiatric disorders. J Child Psychol Psychiatry (2011) 0.84
Corrigendum: Optogenetic dissection of ictal propagation in the hippocampal-entorhinal cortex structures. Nat Commun (2016) 0.80
SnapShot: Autism and the synapse. Cell (2011) 0.79
Striatopallidal dysfunction underlies repetitive behavior in Shank3-deficient model of autism. J Clin Invest (2017) 0.78
Complete deletion of all alpha-dystrobrevin isoforms does not reveal new neuromuscular junction phenotype. Gene Expr (2007) 0.77
Bactericidal thurincin H causes unique morphological changes in Bacillus cereus F4552 without affecting membrane permeability. FEMS Microbiol Lett (2014) 0.76
Striatal magnetic resonance spectroscopy abnormalities in young adult SAPAP3 knockout mice. Biol Psychiatry Cogn Neurosci Neuroimaging (2016) 0.76
Neuroscience: When lights take the circuits out. Nature (2011) 0.75
Unfolding neurodevelopmental disorders: found in translation. Nat Med (2011) 0.75
[Adhesive deformity from the upper eyelid fold formation and its treatment]. Zhonghua Zheng Xing Wai Ke Za Zhi (2002) 0.75
Addendum: A viral strategy for targeting and manipulating interneurons across vertebrate species. Nat Neurosci (2017) 0.75
[Application of facial tissue expander fibrous envelope for tension reduction]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi (2012) 0.75
Corrigendum: A viral strategy for targeting and manipulating interneurons across vertebrate species. Nat Neurosci (2017) 0.75
Reduction of patulin in apple cider by UV radiation. J Food Prot (2010) 0.75
[Animal model of goat cleft palate made by uterine cavitary operations]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi (2010) 0.75
[An experimental study on chemically induced animal model of goat cleft palate in uterus]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi (2011) 0.75
Corrigendum: Opportunities and challenges in modeling human brain disorders in transgenic primates. Nat Neurosci (2017) 0.75
[Effect of in-utero surgical repair at different stages on mid-facial development of goats with cleft palate]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi (2011) 0.75
[One-stage surgical treatment of congenital blepharophimosis syndrome]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi (2007) 0.75